These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. During MJ; Kaplitt MG; Stern MB; Eidelberg D Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246 [TBL] [Abstract][Full Text] [Related]
26. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations. Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145 [TBL] [Abstract][Full Text] [Related]
27. Genetic alterations and DNA repair in human carcinogenesis. Dixon K; Kopras E Semin Cancer Biol; 2004 Dec; 14(6):441-8. PubMed ID: 15489137 [TBL] [Abstract][Full Text] [Related]
28. [Clinical and molecular consequences of microsatellite instability in human cancers]. Hamelin R; Chalastanis A; Colas C; El Bchiri J; Mercier D; Schreurs AS; Simon V; Svrcek M; Zaanan A; Borie C; Buhard O; Capel E; Zouali H; Praz F; Muleris M; Fléjou JF; Duval A Bull Cancer; 2008 Jan; 95(1):121-32. PubMed ID: 18230578 [TBL] [Abstract][Full Text] [Related]
29. [How to consider cancer: implications for the risk due to ionizing radiation]. Piechowski J Bull Cancer; 2005 Nov; 92(11):1007-15. PubMed ID: 16316836 [TBL] [Abstract][Full Text] [Related]
30. Pathogenesis of DNA repair-deficient cancers: a statistical meta-analysis of putative Real Common Target genes. Woerner SM; Benner A; Sutter C; Schiller M; Yuan YP; Keller G; Bork P; Doeberitz Mv; Gebert JF Oncogene; 2003 Apr; 22(15):2226-35. PubMed ID: 12700659 [TBL] [Abstract][Full Text] [Related]
31. Diagnosis and management of medullary thyroid carcinoma. Massoll N; Mazzaferri EL Clin Lab Med; 2004 Mar; 24(1):49-83. PubMed ID: 15157557 [TBL] [Abstract][Full Text] [Related]
33. Increased cell division as a cause of human cancer. Preston-Martin S; Pike MC; Ross RK; Jones PA; Henderson BE Cancer Res; 1990 Dec; 50(23):7415-21. PubMed ID: 2174724 [TBL] [Abstract][Full Text] [Related]
34. Are critical normal gene products in cancer cells the real therapeutic targets? Warenius HM Anticancer Res; 2002; 22(5):2651-5. PubMed ID: 12529977 [TBL] [Abstract][Full Text] [Related]
35. Genetic epidemiology: a powerful approach for the comprehension of cancer etiology. Stazi MA; Sampogna F Ann Ist Super Sanita; 1996; 32(1):167-72. PubMed ID: 8967720 [TBL] [Abstract][Full Text] [Related]
36. The dialectics of cancer: A theory of the initiation and development of cancer through errors in RNAi. Wynter CV Med Hypotheses; 2006; 66(3):612-35. PubMed ID: 16359827 [TBL] [Abstract][Full Text] [Related]
37. [Biological principles for multimodal therapy approaches]. Schackert HK; Bornhäuser M; Dörr W; Frank S Zentralbl Chir; 2000; 125(4):306-14. PubMed ID: 10829309 [TBL] [Abstract][Full Text] [Related]
38. Health-related disparities: influence of environmental factors. Olden K; White SL Med Clin North Am; 2005 Jul; 89(4):721-38. PubMed ID: 15925646 [TBL] [Abstract][Full Text] [Related]
39. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications. Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893 [TBL] [Abstract][Full Text] [Related]